Luminex
Augurex Wins Health Canada Approval for Autoimmune Condition Test
The blood test detects a protein biomarker to aid in the diagnosis of axial spondyloarthritis, which is often mistaken for lower back pain.
Diasorin Nabs FDA 510(k) Clearance for Expanded Respiratory Panel
The firm said that its NxTag Respiratory Pathogen Panel v2 adds detection of the SARS-CoV-2 virus for a total of 21 viral and bacterial targets.
Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance
The quality controls are designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive and Gram-Negative tests.
Decline in DiaSorin's Q2 MDx Revenues Offset by Strength in Immunodiagnostics
Non-COVID-19 immunodiagnostics revenues drove an otherwise strong quarter for DiaSorin with continued growth in North America and Europe and slow improvement in China.
DiaSorin Q1 Revenues Fall 19 Percent on COVID Sales Decline
A 78 percent decline in COVID testing revenues was partially offset by revenue growth in its other diagnostics businesses.